Published in Thorax on April 01, 2010
Severe asthma: anti-IgE or anti-IL-5? Eur Clin Respir J (2016) 0.86
Benralizumab: a unique IL-5 inhibitor for severe asthma. J Asthma Allergy (2016) 0.78
Eosinophil resistance to glucocorticoid-induced apoptosis is mediated by the transcription factor NFIL3. Apoptosis (2016) 0.77
Novel strategies for the treatment of asthma. Allergo J Int (2016) 0.76
Omalizumab Is Equally Effective in Persistent Allergic Oral Corticosteroid-Dependent Asthma Caused by Either Seasonal or Perennial Allergens: A Pilot Study. Int J Mol Sci (2017) 0.75
Transcription Factors in Eosinophil Development and As Therapeutic Targets. Front Med (Lausanne) (2017) 0.75
Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest (1991) 3.88
The use of induced sputum to investigate airway inflammation. Thorax (1997) 3.85
Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med (1999) 3.84
Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis (1990) 3.70
Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2000) 3.63
Non-eosinophilic corticosteroid unresponsive asthma. Lancet (1999) 3.25
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis (1989) 3.06
Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax (2003) 2.93
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest (1986) 2.90
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J (2007) 2.78
Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. BMJ (1993) 2.70
Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax (2002) 2.63
Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet (1990) 2.52
CCR7 expression and memory T cell diversity in humans. J Immunol (2001) 2.42
Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med (1995) 2.25
Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler. BMJ (1992) 2.25
Respiratory medicine: fighting for survival. BMJ (1992) 2.15
The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough. Eur Respir J (2008) 2.01
Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD. Respiration (2009) 1.92
IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology (1990) 1.85
Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur Respir J (2000) 1.81
Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax (2005) 1.81
Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur Respir J (2009) 1.80
Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy (2005) 1.77
Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax (2003) 1.75
Activation of human lung mast cells by monomeric immunoglobulin E. Eur Respir J (2005) 1.74
Human eosinophil, but not neutrophil, adherence to IL-1-stimulated human umbilical vascular endothelial cells is alpha 4 beta 1 (very late antigen-4) dependent. J Immunol (1991) 1.67
Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J Immunol (2001) 1.67
Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med (1991) 1.64
New insights into the role of the mast cell in asthma. Clin Exp Allergy (2003) 1.61
Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood (1992) 1.59
The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. Eur Respir J (1999) 1.58
The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clin Exp Allergy (2005) 1.52
Expression of CCR8 is increased in asthma. Clin Exp Allergy (2010) 1.51
Respiratory symptoms in patients with treated hypothyroidism and inflammatory bowel disease. Thorax (2003) 1.51
New insights into the relationship between airway inflammation and asthma. Clin Sci (Lond) (2002) 1.47
Leukotriene antagonists and symptom control in chronic persistent asthma. Lancet (2001) 1.46
Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design. Eur Respir J (2006) 1.45
Functional KCa3.1 K+ channels are required for human lung mast cell migration. Thorax (2006) 1.39
Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma. Clin Exp Allergy (2003) 1.37
Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med (2001) 1.31
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis. Eur Respir J (2007) 1.30
Adhesion to fibronectin prolongs eosinophil survival. J Exp Med (1993) 1.25
Adhesion of human lung mast cells to bronchial epithelium: evidence for a novel carbohydrate-mediated mechanism. J Leukoc Biol (2000) 1.24
Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med (1999) 1.24
Transfection of cells from patients with leukocyte adhesion deficiency with an integrin beta subunit (CD18) restores lymphocyte function-associated antigen-1 expression and function. J Clin Invest (1990) 1.24
Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease. Clin Exp Allergy (2005) 1.22
Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis. Thorax (2003) 1.19
Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent. J Exp Med (1994) 1.17
Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am J Respir Crit Care Med (2000) 1.15
Expression of endothelial and leukocyte adhesion molecules interacellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma. J Allergy Clin Immunol (1993) 1.14
Asthma control during and after cessation of regular beta 2-agonist treatment. Am Rev Respir Dis (1993) 1.13
Human mast cells express stem cell factor. J Pathol (1998) 1.12
Resting and activation-dependent ion channels in human mast cells. J Immunol (2001) 1.10
IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J Immunol (1995) 1.08
Effects of nedocromil sodium (Tilade) on the activation of human eosinophils and neutrophils and the release of histamine from mast cells. Allergy (1988) 1.07
Structure and regulation of the leukocyte adhesion receptor LFA-1 and its counterreceptors, ICAM-1 and ICAM-2. Cold Spring Harb Symp Quant Biol (1989) 1.07
Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow. Blood (2000) 1.07
Is the neutrophil the key effector cell in severe asthma? Thorax (2005) 1.06
Adenosine monophosphate and histamine induced bronchoconstriction: repeatability and protection by terbutaline. Thorax (1997) 1.02
Mast cells express IL-13R alpha 1: IL-13 promotes human lung mast cell proliferation and Fc epsilon RI expression. Allergy (2006) 1.02
Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy. J Allergy Clin Immunol (1996) 1.02
Chemokines and their receptors as potential targets for the treatment of asthma. Br J Pharmacol (2007) 1.01
Mast cell migration to Th2 stimulated airway smooth muscle from asthmatics. Thorax (2006) 1.01
Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma. J Appl Physiol (1985) (1988) 1.01
Observational study of the natural history of eosinophilic bronchitis. Clin Exp Allergy (2005) 1.01
A case of cough, lymphocytic bronchoalveolitis and coeliac disease with improvement following a gluten free diet. Thorax (2002) 1.00
Sputum induction to assess airway inflammation: is it an inflammatory stimulus? Thorax (1998) 1.00
Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. Eur Respir J (2005) 0.99
IFN-gamma induces expression of Fc gamma RIII (CD16) on human eosinophils. J Immunol (1992) 0.99
Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells. Br J Pharmacol (2009) 0.99
The combined effects of two pairs of mediators, adenosine with methacholine and prostaglandin D2 with histamine, on airway calibre in asthma. Clin Sci (Lond) (1986) 0.98
CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology (1993) 0.98